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Objective: To report prenatal diagnosis of 22q11.2 deletion syndrome in a pregnancy with congenital
heart defects in the fetus.
Case report: A 26-year-old, primigravid woman was referred for counseling at 24 weeks of gestation
because of abnormal ultrasound ﬁndings of fetal congenital heart defects. The Level II ultrasound
revealed a singleton fetus with heart defects including overriding aorta, small pulmonary artery, and
ventricular septal defect. Cordocentesis was performed. The DNA extracted from the cord blood was
analyzed by multiplex ligation-dependent ampliﬁcation (MLPA). The MLPA showed deletion in the
DiGeorge syndrome (DGS) critical region of chromosome 22 low copy number repeat (LCR) 22-A~C.
Conventional cytogenetic analysis revealed a normal male karyotype. Repeated amniocentesis and cor-
docentesis were performed. Whole-genome array comparative genomic hybridization (aCGH) on cord
blood was performed. aCGH detected a 3.07-Mb deletion at 22q11.21. Conventional cytogenetic analysis
of cultured amniocytes revealed a karyotype 46,XY. Metaphase ﬂuorescence in situ hybridization (FISH)
analysis on cultured amniocytes conﬁrmed an interstitial 22q11.2 deletion.
Conclusion: Prenatal ultrasound ﬁndings of congenital heart defects indicate that the fetuses are at
increased risk for chromosome abnormalities. Studies for 22q11.2 deletion syndrome should be
considered adjunct to conventional karyotyping. Although FISH has become a standard procedure for
diagnosis of 22q11.2 deletion syndrome, MLPA can potentially diagnose a broader spectrum of abnor-
malities, and aCGH analysis has the advantage of reﬁning the 22q11.2 deletion breakpoints and detecting
uncharacterized chromosome rearrangements or genomic imbalances.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.cs and Gynecology, Mackay
Road, Taipei, Taiwan.
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bstetrics & Gynecology. PublishedIntroduction
Chromosome 22q11.2 deletion syndrome occurs in approxi-
mately one in 4000 births, and is the most common human dele-
tion syndrome. It encompasses a wide spectrum of abnormalities
including DiGeorge syndrome [Online Mendelian Inheritance in
Man (OMIM) 188400] and velocardiofacial syndrome (OMIMby Elsevier Taiwan LLC. All rights reserved.
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congenital heart diseases, palatal abnormalities, learning difﬁ-
culties, immune deﬁciency, characteristic facial features, and hy-
pocalcemia [1,2]. Individuals with this syndrome have an estimate
high rate of 74% of congenital heart disease, including tetralogy of
Fallot, ventricular septal defect, interrupted aortic arch, and truncus
arteriosus [1,2].
With the advent of ultrasound and molecular genetic technol-
ogy, many cases with 22q11.2 deletion have been diagnosed in the
prenatal period by the use of ﬂuorescence in situ hybridization
(FISH), multiplex ligation-dependent ampliﬁcation (MLPA) and
array comparative genomic hybridization (aCGH) [3e9]. We pre-
sent our experience of prenatal diagnosis of 22q11.2 microdeletion
syndrome by MLPA and aCGH in a fetus with congenital heart
defects.
Case presentation
A 26-year-old, primigravid womanwas referred for counseling at
24 weeks of gestation because of abnormal ultrasound ﬁndings of
fetal congenital heart defects. Her husbandwas 27 years old. She and
her husband were healthy and nonconsanguineous. There was no
family history of congenital malformations. She denied any recent
infections or exposure to teratogens during this pregnancy. The
pregnancy was uneventful until 24 weeks of gestation when Level II
ultrasound revealed a singleton fetus with heart defects including
overriding aorta, small pulmonary artery, and ventricular septal
defect. The amniotic ﬂuid amount and fetal growth were normal.
Other internal organs were unremarkable. Cordocentesis was per-
formed for cytogenetic analysis andmolecular diagnosis of DiGeorge
syndrome. TheDNAextracted fromcordbloodwasanalyzedbyMLPAFig. 1. Whole-genome array comparative genomic hybridization (aCGH) analysis on unc
(18,657,470e21,724,242)  1]. (A) Chromosomal view; (B) zoom-in view.using the SALSA MLPA P250 DiGeorge Probemix (MRC-Holland,
Amsterdam, The Netherlands) according to the manufacturer's pro-
tocol. The MLPA showed a deletion in the DiGeorge syndrome (DGS)
critical region of chromosome 22 low copy number repeat (LCR) 22-
A~C or mlpa 22q LCR22-A~C(P250)  1. Conventional cytogenetic
analysis revealed a normal male karyotype. The parents requested
repeated amniocentesis. Repeated amniocentesis and cordocentesis
were performed.Whole-genomeaCGHon cord bloodwas performed
using a NimbleGen ISCA Plus Cytogenetic Array (Roche NimbleGen,
Madison,WI, USA). aCGH detected a 3.07-Mb deletion at 22q11.21, or
arr 22q11.21 (18,657,470e21,724,242) 1 (Fig. 1). The deleted region
encompasses 126 genes including 43 OMIM genes: USP18, DGCR6,
PRODH, DGCR2, DGCR14, TSSK2, GSC2, SLC25A1, CLTCL1, DVL1P1, HIRA,
MRPL40, UFD1L, CDC45, CLDN5, SEPT5, GP1BB, TBX1, GNB1L, TXNRD2,
COMT, ARVCF, DGCR8, TRMT2A, RANBP1, ZDHHC8, RTN4R, DGCR6L,
GGTLC3, RIMBP3, ZNF74, SCARF2, MED15, PI4KA, SERPIND1, SNAP29,
CRKL, LZTR1, THAP7, P2RX6, SLC7A4, BCRP2, andGGT2. Whole-genome
aCCH analysis on parental bloods revealed no genomic imbalance.
Conventional cytogenetic analysis of cultured amniocytes revealed a
karyotype of 46,XY. FISH analysis was used for conﬁrmation. Meta-
phase FISH analysis on cultured amniocytes using Vysis DiGeorge
region probe [Vysis, LSI TUPLE 1 (Histone cell cycle regulation
defective, s. cerevisiae, homolog of, A (HIRA)) spectrum orange/LSI
ArylsulfataseA (ARSA) spectrumgreen; Abbott Laboratories, Chicago,
IL, USA] showed the presenceof only oneorange signal and twogreen
signals, indicating a deletion of DiGeorge syndrome Tup-like
enhancer of split 1 (TUPLE 1) locus at 22q11.2 in the fetus (Fig. 2). The
karyotype after FISH analysis was 46,XY.ish del(22)(q11.21)(TUPLE
1). The fetus had facial dysmorphism of hypertelorism, prominent
nasal root, bulbous nasal tip, micrognathia, and low-set ears
perinatally.ultured amniocytes shows a 3.07-Mb deletion at 22q11.21 or arr [hg 19] 22q11.21
Fig. 2. Fluorescence in situ hybridization analysis using Vysis LSI TUPLE 1 (HIRA)
spectrum orange/LSI ARSA spectrum green probe set (Abbott Laboratories) shows a
normal chromosome 22 (one orange signal and one green signal) and a del(22)
chromosome (only one green signal) in a metaphase amniocyte.
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The present case was associated with a 3.07-Mb deletion at
22q11.2 encompassing the DGCR6, DGCR2, DGCR14, UFD1L, TBX1,
GNB1L, COMT, DGCR8, DGCR6L, and MED15 genes. Most patients
with 22q11.2 deletion syndrome have been found to have a large
interstitial deletion of 3 Mb containing A-D LCRs. Others have an
atypical shorter deletion within this typically deleted region of A-D
LCRs [1]. In addition to a deletion in the 22q11.2 region, a small
number of patients with features of DiGeorge anomaly have other
chromosome aberrations [10]. Haploinsufﬁciency of the TBX1 gene
(OMIM 602054) is responsible for most of the physical malforma-
tions associatedwith 22q11.2 deletion syndrome [2]. Other possible
responsible genes include DGCR6 (OMIM 601279), DGCR2 (OMIM
600594), DGCR14 (OMIM 601755), UFD1L (OMIM 601754), GNB1L
(OMIM 610778), COMT (OMIM 116790), DGCR8 (OMIM 609030),
DGCR6L (OMIM 609459) and MED15 (OMIM 607372) [2,7].
The present case perinatally manifested conotruncal heart
malformations and craniofacial dysmorphism. Among fetuses with
congenital heart defects, the incidence of chromosomal abnor-
malities ranges from16% to 56% [3,11e15]. Therefore, molecular and
cytogenetic analysis for chromosomal abnormalities should be
considered in prenatally diagnosed congenital heart defects.
Testing for chromosome 22q11.2 deletion is warranted, especially
for conotruncal heart defects [3,4,9,12]. In a prospective study of
1510 cases with structural heart defects identiﬁed on prenatal ul-
trasound, Moore et al [3] found that 41.3% (624 cases) had abnormal
karyotypes. In those fetuses with normal karyotypes that under-
went FISH testing for the deletion of 22q11.2, 3.1% (17 cases) had the
22q11.2 deletion. In a study of 276 pregnancies with abnormal
cardiac ultrasound ﬁndings, Mademont-Solar et al [12] found that
15.9% (44 cases) had chromosomal abnormalities. Of the fetuses
with normal karyotypes, FISH testing revealed 6.4% (5/78) had
22q11.2 deletion syndrome. Among fetuses with normal karyo-
types and negative or no 22q11.2 deletion syndrome study, one
case had pathogenic copy number variants (2%; 1/51) diagnosed by
aCGH [12]. In a retrospective study of 169 pregnancies that un-
derwent FISH testing for 22q11.2 deletion mostly because of con-
otruncal heart defects, Bretelle et al [4] found that 4.7% had the
22q11.2 deletion (8 cases). In a cohort of 61 fetuses with a heart
malformation and normal karyotype, Kjaergaard et al [9] found that
10% (6 cases) had the 22q11 deletion diagnosed by MLPA.
In this case, 22q11.2 deletion syndromewas primarily diagnosed
byMLPA andwas later conﬁrmed by aCGH and FISH. MLPA detecteda deletion in the DGS critical region of LCR22-A~C; and afterward
aCGH detected a 3.07-Mb deletion at 22q11.21 and FISH detected a
deletion of DiGeorge syndrome TUPLE 1 locus at 22q11.2.
MLPA is a novel, PCR-based technique, which was ﬁrst
described by Schouten et al [16]. This molecular method concur-
rently permits the relative quantiﬁcation of up to 45 different
target DNA sequences. It has been used for rapid aneuploidy
diagnosis for common aneuploidy and for diagnosis of several
microdeletion syndromes [9,17,18]. MLPA has proven to be a highly
sensitive, accurate, rapid, and relatively inexpensive tool for
detecting copy number changes in the 22q11.2 region [8,19e21].
The MLPA kit for 22q11.2 deletion syndrome is commercially
available. The probes of the SALSA MLPA P250 DiGeorge Probemix
(MRC-Holland) are arranged according to speciﬁc chromosomal
locations at 22q11 including (1) the Cat eye sundrome (CES) region
covering the genes IL17RA, SLC25A18, BID, MICAL3, and USP18; (2)
LCR22-A~G as follows: LCR22-A covering CLTCL1, HIRA, CDC45L,
CLDN5, GP1BB, TBX1, TXNRD2, and DGCR8; LCR22-B covering
ZNF74, KLHL22, and MED15; LCR22-C covering SNAP29 and LZTR1;
LCR22-D covering HIC2, PPIL2, and TOP3B; LCR22-E covering
RTDR1, GNAZ, RTDR1, and RAB36; LCR22-F covering SMARCB1;
LCR22-G covering SNRPD3; and (3) DiGeorge anomaly-related re-
gions of 4q35, 8p23, 9q34, 10p14 DGS2, 17p13, and 22q13. Features
of DiGeorge anomaly have been observed in patients with chro-
mosome deletions outside chromosome 22 [10]. MLPA can identify
these atypical deletions.
aCGH enables a high-resolution whole-genome screening of
submicroscopic chromosomal imbalance. Several studies have re-
ported the usefulness of aCGH in prenatal diagnosis and the
increased detection rate of chromosomal imbalances, compared
with conventional karyotyping [22e31]. The establishment of the
etiology of congenital heart defects diagnosed prenatally is still
challenging. Mademont-Soler et al [12] and Yan et al [32] reported
the clinical value of aCGH in prenatally diagnosed congenital heart
defects. Mademont-Soler et al [12] found that the diagnostic yield
may be increased by 2% if chromosomal microarray-based analysis
is used as a complementary tool to conventional cytogenetics in
pregnancies with abnormal cardiac ultrasound ﬁndings. Among 76
fetuses with abnormal cardiac ultrasound ﬁndings and normal
karyotype, negative or no FISH results for the 22q11.2 deletion
syndrome, Yan et al [32] found that the incidence of pathogenic
copy number variants was 6.6% (5/76). They suggested that aCGH
can provide additional genetic information in fetuses with
abnormal heart ﬁndings [32].
FISH is the most widely used genetic diagnostic procedure for
the detection of 22q11.2 deletions [3e5,8,15,20]. The FISH study is
usually performed with two probes. One is a chromosome 22-
speciﬁc probe that identiﬁes the chromosome. A second probe
hybridizes to the commonly deleted region. If the second probe is
absent on the speciﬁc chromosome, the diagnosis is established.
The commercially available FISH probes for 22q11.2 analysis are
TUPLE and N25, which are located within LCRs A-B [1]. Despite the
high reliability of the FISH analysis, it is very labor intensive and the
technology requires substantial training. Another issue is that
atypical deletions that do not include LCRs A-B cannot be detected
by commercially available FISH probes [1,2].
Prenatal ultrasound ﬁndings of congenital heart defects indicate
that the fetuses are at increased risk for chromosome abnormal-
ities. Studies for 22q11.2 deletion syndrome should be considered
adjunct to conventional karyotyping. Although FISH has become a
standard procedure for diagnosis of 22q11.2 deletion syndrome,
MLPA can potentially diagnose a broader spectrum of abnormal-
ities, and aCGH analysis has the advantage of reﬁning the 22q11.2
deletion breakpoints and detecting uncharacterized chromosome
rearrangements or genomic imbalances.
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